Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease
Authors not listed
University of Vermont · 2005
Abstract
The primary hypothesis is that quetiapine will improve sleep in persons with Alzheimer's Disease (AD), with higher doses producing greater total sleep time and sleep efficiency.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2005). Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease. <em>University of Vermont</em>. https://clinicaltrials.gov/study/NCT00232570
Vancouver
Anonymous. Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease. University of Vermont. 2005.
BibTeX
@misc{anon2005Quetia,
title = {Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease},
author = {Anonymous},
journal = {University of Vermont},
year = {2005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Free Radical Biology and Medicine 1997
Citation only
Oxidative Stress Hypothesis in Alzheimer's Disease
Free Radical Biology and Medicine 2009
Preprint · OA
Epigenetics, oxidative stress, and Alzheimer disease
Ageing Research Reviews 2020
Preprint · OA
Circadian and sleep dysfunction in Alzheimer’s disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Beijing Friendship Hospital 2015
Open access · US-GOV